methotrexate has been researched along with Inclusion Body Myopathy, Sporadic in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 5 (38.46) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Cash, K; Greenberg, SA; Hissaria, P; Koszyca, B; Limaye, VS; Patel, S; Smith, C | 1 |
| Ferreira, JF; Paiva Dinis, S; Pinto, AS; Rebelo, O; Santos, FC; Vaz, C | 1 |
| Pérez-Berenguer, JL; Varela-Rosario, N; Vilá, LM | 1 |
| Goyal, N; Lavian, M; Mozaffar, T | 1 |
| Iverson, D; Layzer, R; Lee, HS; Margeta, M | 1 |
| Allenbach, Y; Benveniste, O; Brady, S; Dubourg, O; Eymard, B; Freebody, J; Guiguet, M; Herson, S; Hilton-Jones, D; Leite, MI; Maisonobe, T; Squier, W; Stojkovic, T | 1 |
| Dzięgiel, P; Misterska-Skóra, M; Sebastian, A; Sebastian, M; Wiland, P | 1 |
| Lindberg, C; Oldfors, A; Tarkowski, A; Trysberg, E | 1 |
| Derk, CT; Kenyon, L; Mandel, S; Vivino, FB | 1 |
| Amato, AA; Barohn, RJ; Bryan, WW; Gronseth, GS; Jackson, CE; Katz, JS; Wolfe, GI | 1 |
| Levine, TD; Pestronk, A | 1 |
| Lochmüller, H; Müller-Felber, W; Pongratz, D; Reilich, P; Schlotter, B; Walter, MC | 1 |
| Badrising, UA; Breedveld, FC; de Jager, AE; de Visser, M; Ferrari, MD; Hoogendijk, JE; Höweler, CJ; Jennekens, FG; Koehler, PJ; Maat-Schieman, ML; van Doorn, PA; van Engelen, BG; Verschuuren, JJ; Viddeleer, A; Wessels, JA; Wintzen, AR; Zwinderman, AH | 1 |
2 review(s) available for methotrexate and Inclusion Body Myopathy, Sporadic
| Article | Year |
|---|---|
Inclusion body myositis in connective tissue disorders: case report and review of the literature.
Topics: Biopsy, Needle; Drug Therapy, Combination; Female; Humans; Immunohistochemistry; Lupus Erythematosus, Systemic; Methotrexate; Middle Aged; Myositis, Inclusion Body; Prednisone; Prognosis; Risk Assessment; Severity of Illness Index; Sjogren's Syndrome; Treatment Outcome | 2003 |
[New insights in pathogenesis and therapy of sporadic inclusion body myositis (s-IBM)].
Topics: Aged; Antilymphocyte Serum; Crystallins; Drug Therapy, Combination; Gene Expression Regulation; Genetic Predisposition to Disease; Humans; Immunosorbent Techniques; Immunosuppressive Agents; Immunotherapy; Methotrexate; Middle Aged; Myosin Heavy Chains; Myositis, Inclusion Body; NF-kappa B; Physical Therapy Modalities | 2001 |
2 trial(s) available for methotrexate and Inclusion Body Myopathy, Sporadic
| Article | Year |
|---|---|
Anti-T-lymphocyte globulin treatment in inclusion body myositis: a randomized pilot study.
Topics: Aged; Aged, 80 and over; Antilymphocyte Serum; Autoimmune Diseases; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Muscle Contraction; Myositis, Inclusion Body; Pilot Projects; Prospective Studies; T-Lymphocytes; Treatment Outcome | 2003 |
Comparison of weakness progression in inclusion body myositis during treatment with methotrexate or placebo.
Topics: Administration, Oral; Aged; Creatine Kinase; Disease Progression; Double-Blind Method; Enzyme Inhibitors; Female; Humans; Male; Methotrexate; Middle Aged; Muscle Weakness; Myositis, Inclusion Body; Placebos; Treatment Failure | 2002 |
9 other study(ies) available for methotrexate and Inclusion Body Myopathy, Sporadic
| Article | Year |
|---|---|
Inclusion-body myositis and primary Sjögren syndrome: mechanisms for shared etiologies.
Topics: 5'-Nucleotidase; Adult; Autoantibodies; Azathioprine; CD8-Positive T-Lymphocytes; Female; Haplotypes; HLA Antigens; Humans; Hydroxychloroquine; Immunoglobulins, Intravenous; Immunologic Factors; Leukemia, Large Granular Lymphocytic; Magnetic Resonance Imaging; Methotrexate; Muscle, Skeletal; Myositis, Inclusion Body; Prednisolone; Rituximab; Sjogren's Syndrome | 2020 |
Inclusion body myositis and muscular granulomas - a rare finding.
Topics: Accidental Falls; Aged; Antirheumatic Agents; Diagnosis, Differential; Granuloma; Hand Strength; Humans; Male; Methotrexate; Muscle Weakness; Muscle, Skeletal; Myositis, Inclusion Body | 2021 |
Efficacy of immunosuppressive treatment in a systemic lupus erythematosus patient presenting with inclusion body myositis.
Topics: Aged; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Methotrexate; Myositis, Inclusion Body; Prednisone; Treatment Outcome | 2016 |
Sporadic inclusion body myositis misdiagnosed as idiopathic granulomatous myositis.
Topics: Aged; Biomarkers; Diagnosis, Differential; Diagnostic Errors; Disease Progression; Female; Humans; Immunosuppressive Agents; Methotrexate; Muscle, Skeletal; Myositis, Inclusion Body | 2016 |
Dermatomyositis with inclusion body myositis pathology.
Topics: Anti-Inflammatory Agents; Antigens, CD; Dermatologic Agents; Dermatomyositis; Humans; Male; Methotrexate; Middle Aged; Muscle Fibers, Skeletal; Myositis, Inclusion Body; Prednisone; T-Lymphocytes; Treatment Outcome | 2009 |
Long-term observational study of sporadic inclusion body myositis.
Topics: Aged; Azathioprine; Cohort Studies; Disability Evaluation; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Muscle Weakness; Muscle, Skeletal; Myositis, Inclusion Body; Prednisone | 2011 |
Inclusion body myositis associated with Sjögren's syndrome.
Topics: Comorbidity; Female; Humans; Methotrexate; Methylprednisolone; Middle Aged; Myositis, Inclusion Body; Quality of Life; Sjogren's Syndrome; Treatment Outcome | 2013 |
Inclusion body myositis: clinical and pathological boundaries.
Topics: Aged; Azathioprine; Biopsy; Creatine Kinase; Dermatomyositis; Diagnosis, Differential; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Muscle Weakness; Muscle, Skeletal; Myositis, Inclusion Body; Polymyositis; Retrospective Studies; Treatment Outcome | 1996 |
Inflammatory myopathy with cytochrome oxidase negative muscle fibers: methotrexate treatment.
Topics: Aged; Electron Transport Complex IV; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Muscle Fibers, Skeletal; Muscle, Skeletal; Myositis; Myositis, Inclusion Body; Treatment Outcome | 1998 |